Pfizer-Piramal deal gets CCI’s nod

21 Sep 2016 Evaluate

Competition Commission of India (CCI) has given its nod to Pfizer-Piramal where Piramal Enterprises’ proposed acquisition of four brands from pharmaceutical major Pfizer.

As per the deal announced in May, Piramal Enterprises’ consumer products division entered into an agreement to acquire Ferradol, Neko, Sloan’s and Waterbury’s Compound brands for a consideration of Rs 110 crore. The deal also included trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4595.60 -127.70 (-2.70%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×